The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round. Generate Biomedicines is touting […]
Generate Biomedicines
Trending topics and news from the Generate Biomedicines category
Back to news home